Tiffany Eul Davis Inglis
CIK 2091798 · Chief Medical Officer · last filed 2026-06-15
Tiffany Eul Davis Inglis is a Chief Medical Officer who has filed 4 SEC Form 4 insider transactions across 1 company since 2025. The most recent filing shows the insider sold $728 of SERA on Jun 15, 2026. Across all open-market trades the lifetime net is −$728, making them a net seller over the disclosed history. Current disclosed insider exposure totals $186.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$186.9K
1
4
-$728
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SERA | Chief Medical Officer | 92,075 | $2.03 | $186.9K | -$728 | 3 | 2026-06-15 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-15 | SERA | Sell (S) | −362 | -$728 | EDGAR |
| 2026-06-15 | SERA | Notice (144) | −362 | -$726 | EDGAR |
| 2026-03-13 | SERA | Grant (A) | +17,437 | $0 | EDGAR |
| 2025-10-15 | SERA | Grant (A) | +75,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.